SCHEMBL8739253

SCHEMBL8739253

CN(C)CCNC(=O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.68
MCHR1 Q99705 3/20 0.64
CA12 O43570 1/20 0.62
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
MMP2 P08253 1/20 0.62
CA9 Q16790 1/20 0.62
FYN P06241 2/20 0.61
RAD52 P43351 1/20 0.61
ALOX5 P09917 1/20 0.60
HPGD P15428 1/20 0.57
MMP1 P03956 1/20 0.57
MAPK14 Q16539 2/20 0.57
UTS2R Q9UKP6 1/20 0.55
MMP13 P45452 2/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4447089 0.99 ALDH1A1 (0.66) ALDH1A1MCHR1CA12CA1CA2
SCHEMBL8738694 0.92 MCHR1 (0.66) ALDH1A1MCHR1CA12CA1CA2
SCHEMBL13886658 0.90 MCHR1 (0.62) ALDH1A1MCHR1CA12CA1CA2
Hydrochloric Acid SCHEMBL4454385 0.90 MCHR1 (0.65) ALDH1A1MCHR1CA12CA1CA2
SCHEMBL13886655 0.89 MCHR1 (0.61) ALDH1A1MCHR1CA12CA1CA2
Hydrochloric Acid SCHEMBL4456308 0.89 MCHR1 (0.61) ALDH1A1MCHR1CA12CA1CA2
Hydrochloric Acid SCHEMBL4449710 0.88 MCHR1 (0.60) ALDH1A1MCHR1CA12CA1CA2
SCHEMBL18645537 0.87 CA12 (0.54) ALDH1A1MCHR1CA12CA1CA2
SCHEMBL2087431 0.86 ALDH1A1 (0.62) ALDH1A1ALOX5HPGDLMNASMN1; SMN2
SCHEMBL18645008 0.85 MCHR1 (0.54) ALDH1A1MCHR1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012068589-A2 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF CONSTELLATION PHARMACEUTICALS (US) 2012-05-24 WO disclosed
US-20090105347-A1 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-04-23 US disclosed
US-20090105347-A1 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-04-23 US disclosed
US-7355079-B2 Thyronamine derivatives and analogs and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-04-08 US disclosed
US-7355079-B2 Thyronamine derivatives and analogs and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-04-08 US disclosed
US-7321065-B2 Thyronamine derivatives and analogs and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-01-22 US disclosed
US-7321065-B2 Thyronamine derivatives and analogs and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105347-A1 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF TPO, TSHR, THRB ALDH1A1 2156/4885MCHR1 1420/4885CA12 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.